Search Results
Found 1 results
510(k) Data Aggregation
(141 days)
Genius AI Detection is a computer-aided detection and diagnosis (CADe/CADx) software device intended to be used with compatible digital breast tomosynthesis (DBT) systems to identify and mark regions of interest including soft tissue densities (masses, architectural distortions and asymmetries) and calcifications in DBT exams from compatible DBT systems and provide confidence scores that offer assessment for Certainty of Findings and a Case Score. The device intends to aid in the interpretation of digital breast tomosynthesis exams in a concurrent fashion, where the interpreting physician confirms or dismisses the findings during the reading of the exam.
Genius Al Detection is a software device intended to identify potential abnormalities in breast tomosynthesis images. Genius Al Detection analyzes each standard mammographic view in a digital breast tomosynthesis examination using deep learning networks. For each detected lesion, Genius Al Detection produces CAD results that include the location of the lesion, an outline of the lesion and a confidence score for that lesion. Genius Al Detection also produces a case score for the entire tomosynthesis exam.
Genius AI Detection packages all CAD findings derived from the corresponding analysis of a tomosynthesis exam into a DICOM Mammography CAD SR object and distributes it for display on DICOM compliant review workstations. The interpreting physician will have access to the CAD findings concurrently to the reading of the tomosynthesis exam. In addition, a combination of peripheral information such as number of marks and case scores may be used on the review workstation to enhance the interpreting physician's workflow by offering a better organization of the patient worklist.
Here's a breakdown of the acceptance criteria and the study proving the device meets them, based on the provided FDA 510(k) summary:
Acceptance Criteria and Reported Device Performance
The document states that the new device, Genius AI Detection 2.0, aims to improve performance, mainly in terms of improved specificity, particularly for micro-calcification cancer detection, while maintaining sensitivity. The study confirms this improvement.
Acceptance Criteria Category | Specific Criterion | Reported Device Performance |
---|---|---|
Detection Performance: | Improved specificity over the predicate device, especially for micro-calcification cancer detection. | The specificity measured at the operating point of Genius AI Detection 2.0 demonstrated a significant increase of 12% compared to the original Genius AI Detection predicate device (McNemar's p |
Ask a specific question about this device
Page 1 of 1